Latest Asia Pacific Expansion News

Page 2 of 2

Neuren’s DAYBUE Sales Climb 11% as European Launch Nears

Neuren Pharmaceuticals reports a robust 11% rise in DAYBUE™ US net sales for Q1 2025, alongside a 17% jump in royalty income, setting the stage for an anticipated European market entry in early 2026.

Victor Sage

8 May 2025

Top